Blood Plasma Derivatives Market garner about $44,333 million,Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecasts to 2023

Blood plasma is a pure liquid component in the blood, with red blood cells, white blood cells and thrombocytes ceasing. It plays a vital role in keeping the body's pH balanced and carrying nutrients throughout the body. It consists of more than 100 different proteins, including albumin, fibrinogen, immunoglobulins, protease inhibitors, and clotting factors. Plasma derivatives are those products that come from the blood plasma and are widely used to treat various diseases. These derivatives include albumin, factor VIII and IX, anti-infectious coagulation complex (AICC), immunoglobulins, including Rh immune globulin alpha 1-proteinase inhibitor concentrate, and anti-thrombin III concentrate.

According to a new report published by Allied Market Research, titled, Blood Plasma Derivatives Market, by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global blood plasma derivatives market was valued at $23,613 million in 2016, and is projected to reach $44,333 million in 2023, registering a CAGR of 9.3% from 2017 to 2023.

Get sample copy of this report :
www.alliedmarketresearch.com/request-sample/656?utm_source=Prathm_OPR

Key Findings of the Blood Plasma Derivatives Market:

• The albumin segment accounted for nearly one-sixth share of the global blood plasma derivatives market in 2016.

• The immunoglobulins segment is expected to grow at highest CAGR from 2017 to 2023.

• The immunodeficiency diseases segment accounted for around one-third share of the global market in 2016.

• Europe accounted for around one-third share of the global market in 2016.

• LAMEA is expected to provide lucrative market growth opportunities from 2017 to 2023.

North America was the leading revenue contributor to the global blood plasma derivatives market in 2016, and is expected to dominate the market during the forecast period. This is attributed to the early approval of plasma derivatives products and large number of fractionation plants in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards plasma derivatives.

Send Enquiry on this report @
www.alliedmarketresearch.com/purchase-enquiry/656?utm_source=Prathm_OPR

The factors that drive the growth of the blood plasma derivatives market include increase in prevalence of life-threatening diseases such as immunodeficiency diseases and hemophilia, rise in awareness towards blood & plasma donation, upsurge in geriatric population, and growth in adoption of blood plasma derivatives products. However, high cost of plasma derivative-based treatment and risk of side effects associated after using plasma derivatives impede the market growth. Conversely, the development of superior methods for preservation of plasma derivatives along with advanced processes for fractionation and presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.

The immunoglobulin segment accounted for the largest share in 2016, owing to high usage & applicability for treating variety of immunodeficiency diseases and improved immunoglobulin production due to the emergence of advanced technologies. However, the albumin segment is expected to grow at the high CAGR from 2017 to 2023.

Top key players :

• Grifols
• S.A.
• SK Plasma Co. Ltd.
• Fusion Health Care Pvt. Ltd.
• Biotest AG
• Green Cross Corporation
• Baxter International Inc.
• LFB S.A.
• Octapharma AG
• CSL Limited
• Shire Plc.

Table of content :

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. By Type
1.3.2. By Application
1.3.3. By End User
1.3.4. By Region
1.3.5. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. High prevalence of life threatening diseases
3.4.1.2. Growth in awareness about blood and plasma donation
3.4.1.3. Rise in geriatric population
3.4.1.4. High adoption of blood plasma derivatives

3.4.2. Restraints

3.4.2.1. High cost of blood plasma derivatives based therapy
3.4.2.2. Risks associated with plasma derivatives

3.4.3. Opportunities

3.4.3.1. Development of better methods for plasma derivatives manufacturing
3.4.3.2. Opportunities in emerging economies

3.4.4. Impact analyses

3.5. Government regulations

3.5.1. Plasma derivatives regulations in United States and Europe

Access Full Summary at : www.alliedmarketresearch.com/blood-plasma-derivatives-market?utm_source=Prathm_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Deep joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.